Sunshine Biopharma (SBFM) Gross Margin (2018 - 2026)
Sunshine Biopharma's (SBFM) quarterly Gross Margin came in at 26.96% in Q1 2026, down 371.0% YoY from 9.95% in Q1 2025, and down 23.65% on a QoQ basis from 35.31% in Q4 2025.
Sunshine Biopharma (SBFM) Gross Margin (2018 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 9 years of Gross Margin data on file, last reported at 26.96% in Q1 2026.
- Quarterly Gross Margin fell 371.0% year-over-year to 26.96% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 32.98% (up 250.0% YoY) and the FY2025 annual result came in at 33.76%, up 316.0% from the prior year.
- Gross Margin slipped to 26.96% in Q1 2026, from 35.31% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 51.2% in Q1 2022 to a low of 25.33% in Q2 2024.
- A 5-year average of 36.11% and a median of 33.98% in 2024 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2023 — Gross Margin plunged 1706 bps — and 2025, when it soared 1105 bps.
- Tracing SBFM's Gross Margin over 5 years: stood at 37.85% in 2022, then declined by 12 bps to 33.44% in 2023, then declined by 4 bps to 32.24% in 2024, then climbed by 10 bps to 35.31% in 2025, then declined by 24 bps to 26.96% in 2026.
- The last three Gross Margin figures came in at 26.96% (Q1 2026), 35.31% (Q4 2025), and 32.64% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Sunshine Biopharma | 1.54 Mn | -12.21 Mn | 2.43 Mn | 26.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.20% |
| Mar 31, 2026 | 26.96% |
| Dec 31, 2025 | 35.31% |
| Sep 30, 2025 | 32.64% |
| Jun 30, 2025 | 36.37% |
| Mar 31, 2025 | 30.67% |
| Dec 31, 2024 | 32.24% |
| Sep 30, 2024 | 33.98% |
| Jun 30, 2024 | 25.33% |
| Mar 31, 2024 | 31.22% |
| Dec 31, 2023 | 33.44% |
| Sep 30, 2023 | 33.41% |
| Jun 30, 2023 | 35.12% |
| Mar 31, 2023 | 37.35% |
| Dec 31, 2022 | 37.85% |
| Sep 30, 2022 | 50.47% |
| Jun 30, 2022 | 50.31% |
| Mar 31, 2022 | 51.20% |
| Dec 31, 2021 | 28.00% |
| Sep 30, 2021 | 61.28% |